Show
Sort by
-
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)
-
- Journal Article
- A1
- open access
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer : a phase 2 adaptive trial
-
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1) : final survival analysis of a randomised, controlled, phase 3 trial